EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity

Douglas A Gaskarth, Shujun Fan, Andrew J Highton, Roslyn A Kemp

Frontiers in Medicine · 24.06.2025 · 12

DOI: 10.3389/fmed.2025.1577906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 24.06.2025. Verfasst von Douglas A Gaskarth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

CD8+ T cells are vital in the immune control of cancer and a key player in cell-based cancer immunotherapy. Recent studies have shown that microbial short-chain fatty acids (SCFA) can promote both effector and memory phenotypes in CD8+ T cells and may thereby enhance protection against cancer.

Methods

In this study, we determined the effect of SCFA butyrate on mouse CD8+ T cell function in vitro and in vivo , using the OT-I model.

Results

Butyrate co-culture with anti-CD3 + anti-CD28 activated T cells in vitro enhanced the frequency of effector CD8+ IFN-γ-producing cells, and the amount of cytokine produced per cell. Culture with butyrate also enhanced the activation, TCR expression, and levels of phosphorylated mTOR proteins within CD8+ T cells but reduced proliferation rate and increased apoptosis. Butyrate-treated activated cells conferred tumor protection after adoptive transfer. Butyrate-treated cells were present at higher frequencies within the tumor compared to non-butyrate treated cells, and expressed IFN-γ. When analyzed using high dimensional cytometry, the tumors of mice that received butyrate-treated cells were enriched in clusters displaying an effector memory phenotype with high expression of IL-15Rβ and T-bet.

Discussion

Our findings show that butyrate promotes the effector activity of CD8+ T cells in culture, which can persist in vivo while also stimulating memory phenotypes. Consequently, butyrate treatment may have strong application in T cell-based immunotherapies to improve protective cell functions and patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

T cell memoryCD8+ T cellsactivationbutyratecancereffector functionimmunotherapyshort-chain fatty acids

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

Zitieren

APA

Gaskarth, D. A., Fan, S., Highton, A. J., & Kemp, R. A. (2025). The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1577906

Vancouver

Gaskarth DA, Fan S, Highton AJ, Kemp RA. The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1577906

BibTeX
@article{Gaskarth2025,
  author = {Gaskarth, Douglas A and Fan, Shujun and Highton, Andrew J and Kemp, Roslyn A},
  title = {The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity},
  journal = {Frontiers in Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fmed.2025.1577906}
}
Kostenlos starten →